GeneDx Holdings (WGS) Inventory Average (2021 - 2026)

GeneDx Holdings (WGS) has 6 years of Inventory Average data on file, last reported at $13.1 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $13.1 million, up 12.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.1 million (up 12.35% YoY), and the FY2025 annual result was $12.3 million, up 26.63% from the prior year.
• Inventory Average climbed to $13.1 million in Q1 2026 per WGS's latest filing, from $12.3 million in the prior quarter.
• Over five years, Inventory Average peaked at $42.9 million in Q3 2022 and troughed at $9.1 million in Q4 2023.
• A 5-year average of $17.2 million and a median of $11.9 million in 2023 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2023: Inventory Average jumped 42.24% in 2022, then plunged 75.66% in 2023.
• A 5-year view of Inventory Average shows it stood at $28.9 million in 2022, then slumped by 68.66% to $9.1 million in 2023, then advanced by 18.17% to $10.7 million in 2024, then advanced by 14.47% to $12.3 million in 2025, then advanced by 6.82% to $13.1 million in 2026.
• Business Quant data shows WGS's Inventory Average at $13.1 million in Q1 2026, $12.3 million in Q4 2025, and $11.3 million in Q3 2025.